As the Division of Examinations of the Securities and Exchange Commission (SEC) unveiled its 2025 examination priorities, a broad spectrum of issues for registered investment advisers, investment companies, and broker-dealers comes into focus. Published on October 21, 2024, this document underscores significant themes expected to resonate throughout the upcoming year.


The priorities, while reflecting potential shifts due to the changing presidential administration, maintain steadfast core areas, suggesting continuity in enforcement actions. A comprehensive review highlights the Division’s focus on private fund advisers, cybersecurity, and the utilization of artificial intelligence, emphasizing long-standing commitments alongside new regulatory amendments.


Investment Advisers

For investment advisers, the SEC will enhance oversight on those who have never undergone an examination or have been recently registered. Key review components will include fiduciary standards, compliance programs, and private fund advisers, particularly in volatile markets like commercial real estate and crypto assets.


Broker-Dealers

Broker-dealers will be scrutinized regarding Regulation Best Interest (Reg BI) and Form CRS obligations. The focus will be on assessing the alignment of broker-dealer practices with customer interests, especially concerning complex and high-risk products.


Risk Areas and Technology

Cybersecurity remains a cornerstone in the SEC’s examination strategy, ensuring entities have robust governance and protection measures. Similarly, the rise of artificial intelligence and its integration into financial services draws sharp scrutiny to ensure compliance and mitigate potential risks.


In conclusion, while the 2025 examination priorities from the SEC provide a roadmap for regulatory focus, they also serve as a vital tool for entities to self-evaluate and reinforce their compliance frameworks against potential risks, safeguarding investors and market integrity.


For more information, view the full article on Stinson LLP’s website.


Authored by Eric Mikkelson & Carissa Occhipinto, Stinson LLP

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

Exploring the Benefits and Risks of AI in Oncology

The potential of AI to transform medical services is immense. From enhancing diagnostic precision to personalizing treatment options, AI is poised to play a pivotal role in the future of healthcare.

By |January 17, 2025|Categories: Article, Artificial Intelligence, Healthcare|Tags: , |0 Comments

The Future of Oncology: How TechBio is Revolutionizing Cancer Treatment and Beyond

The future of oncology is about more than conquering cancer; it’s an opportunity to redefine healthcare access and equity worldwide, ensuring hope and healing for all.

By |January 17, 2025|Categories: Article, Oncology, TechBio|Tags: , |0 Comments

Telehealth: A New Frontier in Equitable Healthcare Access

"Telehealth" offers a promising avenue to bridge these gaps. By facilitating the provision of specialists, reducing travel needs, and ensuring culturally sensitive care. "Telehealth" promotes health inclusivity.

By |January 16, 2025|Categories: Article, Healthcare, Technology|Tags: , |0 Comments

Heart Attack Diagnostics Market Surges with Technological Innovations

The heart attack diagnostics market is poised for remarkable growth, driven by groundbreaking advancements in artificial intelligence, biomarkers, and cutting-edge imaging technologies.

By |January 16, 2025|Categories: Article, Healthcare, Technology|Tags: , |0 Comments

ClearValue Consulting Teams Up with Restb.ai to Revolutionize Real Estate Appraisals

In a bold move to transform the real estate appraisal landscape, ClearValue Consulting has announced a strategic partnership with Restb.ai. This collaboration is set to integrate cutting-edge computer vision technology into ClearValue's renowned valuation review platform, Certainty, bringing about a new era of efficiency and precision in appraisal processes.

Artificial Intelligence: The New Frontier in Combating Infectious Diseases

AI is transforming how we diagnose and treat infectious diseases, particularly in the realm of antibiotic resistance. Traditional methods of discovering new antibiotics are notoriously slow, often taking years to yield results. However, AI is accelerating this process dramatically.